Clinical Trials in San Francisco

Showing 10541-10560 of 12,991 trials

Determining the Safety of L-serine in ALS

NCT01835782

The purpose of this study is to determine the safety of L-Serine in subjects with Amyotrophic Lateral Sclerosis (ALS) at varied doses.

Amyotrophic Lateral Sclerosis (ALS)

Phoenix Neurological Associates, LTD20 participantsStarted Jan 2013

Phoenix, Arizona, United States • San Francisco, California, United States

COMPLETEDPhase 2< 1 mile

Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)

NCT00565058

This is a Phase II trial conducted at multiple centers for evaluation of the pharmacodynamic activity and the overall response rate contributed by the combination agents of GTI-2040 and High Dose Cytarabine (HiDAC) in Refractory and Relapsed Acute Myeloid Leukemia (AML).

Acute Myeloid Leukemia

Aptose Biosciences Inc.27 participantsStarted Aug 2007

San Francisco, California, United States • San Francisco, California, United States • Atlanta, Georgia, United States +4 more locations

TERMINATEDPhase 2< 1 mile

A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma

NCT01227434

This study will determine the efficacy of the small molecule CDK4/6 inhibitor PD 0332991 (as measured by progression free survival at 6 months) in patients with recurrent glioblastoma multiforme or gliosarcoma who are Rb positive. A total of 30 patients will be treated; 15 will undergo a planned surgical resection and receive drug for 7 days prior to surgery, followed by drug after recovery from surgery, and the other 15 patients will receive drug without a planned surgical procedure.

GlioblastomaGliosarcomaAnaplastic Astrocytoma

University of California, San Francisco23 participantsStarted Sep 2010

San Francisco, California, United States

Determining the Safety of L-serine in ALS

Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)

A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma

Find Trials by Condition in San Francisco

A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT)

Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant

TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients

Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Rollover Study of VX-770 in Cystic Fibrosis Subjects

A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)

A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas

A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary Fibrosis

A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA

Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for the Treatment of Cold Sores

Work Injury Prevention in Law Enforcement Officials

A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in the Emergency Department

Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer